Adjuvant endocrinotherapy of postmenopausal patients with breast cancer

Adjuvant endocrinotherapy of postmenopausal patients with breast cancer

Adjuvant endocrinotherapy of postmenopausal patients with breast cancer

Bibliographic Details
Main Authors:	V. F. Semiglazov, A. A. Malodusheva, V. G. Ivanov, P. V. Krivorotko
Format:	Article
Language:	Russian
Published:	ABV-press 2014-09-01
Series:	Опухоли женской репродуктивной системы
Online Access:	https://ojrs.abvpress.ru/ojrs/article/view/363

Similar Items

Adjuvant endocrinotherapy of breast cancer (part I)
by: N. Yu. Dobrovolskaya, et al.
Published: (2014-09-01)

Importance of evaluation of ovarian function in women with breast cancer when using endocrinotherapy
by: I. B. Kononenko, et al.
Published: (2018-07-01)

ROLE OF MORPHOLOGICAL AND GENETIC STRUCTURAL CHARACTERISTICS OF ESTROGEN RECEPTOR ALPHA IN THE DEVELOPMENT OF RESISTANCE TO ENDOCRINOTHERAPY WITH TAMOXIFEN IN PATIENTS WITH LUMINAL BREAST CANCER
by: Е. М. Slonimskaya, et al.
Published: (2016-02-01)

ADJUVANT HORMONE THERAPY ELIGIBILITY OF PREMENOPAUSAL WOMEN WITH ER+ BREAST CANCER
by: V. F. SEMIGLAZOV, et al.
Published: (2017-06-01)

Is the extension of adjuvant hormone therapy for breast cancer justified?
by: V. F. Semiglazov, et al.
Published: (2020-07-01)

Future prospects for breast cancer immunotherapy
by: V. F. Semiglazov, et al.
Published: (2018-11-01)

Adjuvant therapy in premenopausal women with hormone-dependent breast cancer
by: V. F. Semiglazov, et al.
Published: (2018-11-01)

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists)
by: V. F. Semiglazov, et al.
Published: (2015-09-01)

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
by: T. Yu. Semiglazova, et al.
Published: (2014-07-01)

Complexité de l’adhésion à l’endocrinothérapie adjuvante après un cancer du sein
by: Leah K. Lambert, et al.
Published: (2021-05-01)

Adjuvant hormone therapy in postmenopausal patients with locally advanced breast cancer: hope and reality
by: V. I. Borisov
Published: (2014-07-01)

Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
by: T Yu Semiglazova, et al.
Published: (2015-03-01)

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
by: V. F. Semiglazov, et al.
Published: (2018-07-01)

New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
by: T Yu Semiglazova, et al.
Published: (2016-06-01)

The role of tumor-infiltrating lymphocytes, prognostic and predictive signification in breast cancer
by: A. Tseluiko, et al.
Published: (2021-04-01)

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women
by: Muaiad Kittaneh, et al.
Published: (2011-01-01)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus’ko, et al.
Published: (2017-02-01)

Biopsychosocial approach in the rehabilitation of patients with operable breast cancer
by: V. A. Kluge, et al.
Published: (2020-07-01)

Post-neoadjuvant treatment of breast cancer
by: V. F. Semiglazov, et al.
Published: (2020-07-01)

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases
by: T. Yu. Semiglazova, et al.
Published: (2021-06-01)

Male breast cancer: review of the literature
by: K S Nikolaev, et al.
Published: (2014-12-01)

Immunology and immunotherapy in breast cancer
by: Vladimir Semiglazov, et al.
Published: (2022-05-01)

NEW ADVANCES IN THE TREATMENT OF BREAST CANCER: THE ROLE EPOTHILONES
by: T. Y. SEMIGLAZOVA, et al.
Published: (2017-06-01)

Strategy of post-neoadjuvant treatment of patients with residual breast cancer
by: V. V. Semiglazov, et al.
Published: (2020-06-01)

General recommendations for the management of breast cancer (St. Gallen Expert Consensus developed at the 16<sup>th </sup>th International Breast Cancer Conference)
by: V. F. Semiglazov, et al.
Published: (2020-03-01)

Angiosome theory findings using new protocol of CT-angiography improves outcomes in DIEP-flap reconstruction surgery in breast cancer patients
by: R. Pesotsky, et al.
Published: (2021-04-01)

Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple negative breast cancer (TNBC)
by: P. Krivorotko, et al.
Published: (2021-04-01)

New prospects in the use of Kadcyla® in breast cancer
by: G. A. Dashyan, et al.
Published: (2015-11-01)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
by: V F Semiglazov, et al.
Published: (2013-12-01)

Utility of dual-energy contrast-enhanced spectral mammography for the diagnosis of multicentric breast cancer
by: A. V. Chyornaya, et al.
Published: (2022-01-01)

ADJUVANT CHEMOTHERAPY OF PRIMARY OPERABLE LUMINAL B BREAST CANCER WITHOUT OVEREXPRESSION OF HER2/NEU IN POSTMENOPAUSAL WOMEN: YES OR NO?
by: Yu. S. Shatova, et al.
Published: (2017-12-01)

IMMUNOLOGICAL IMBALANCE IN BREAST CANCER AND LUNG CANCER IN POSTMENOPAUSAL WOMEN
by: A. N. Glushkov, et al.
Published: (2018-12-01)

Effectivness of breast-conserving treatment for minimal residual tumors after neoadjuvant breast cancer therapy
by: R. Pesotsky, et al.
Published: (2021-04-01)

CHEMOTHERAPY BREAST CANCER MODERN VIEW ON THE PROBLEM
by: V. F. SEMIGLAZOV, et al.
Published: (2017-06-01)

Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy
by: Romy Aarnoutse, et al.
Published: (2022-07-01)

Twenty-year experience of examining biopsies of signal lymph nodes in breast cancer
by: V. F. Semiglazov, et al.
Published: (2020-06-01)

The role of digital mammography, scintimammography with <sup>99m </sup>Tc-methoxyisobutylisonitrile (MIBI) and ultrasound in the diagnosis of multicentric breast cancer
by: A. V. Chernaya, et al.
Published: (2020-03-01)

COMPARATIVE ANALYSIS OF DIFFERENT NEOADJUVANT CHEMOTHERAPY REGIMENS FOR TRIPLE-NEGATIVE BREAST CANCER
by: P. V. Krivorotko, et al.
Published: (2017-12-01)

The effects of tualang honey on bone mineral density as an adjuvant therapy to anastrozole among postmenopausal breast cancer patients
by: Hassan, Nor Hasnina Mohd
Published: (2016)